4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-035937
CEO and CFO bought 1,000 shares at $13.01 ($13,010)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-12-16 | Purchase | +1,000 | $13.01 | $13,010 | 2,725,886 | D |
| Open-market purchases · 1,000 sh · avg $13.01 · $13,010 | |||||||
Loading xslF345X03/ownership.xml…